Best Practices for Updating Analytical Procedures in Drug Development and Manufacturing

Expert Forum

Your registration was successful, so you can now watch and attend the on-demand presentation.

If you know a colleague who would benefit from this presentation, use the form to invite them.

After watching the presentation(s), please take a moment to share your extremely valuable insights. It will only take a few minutes.

Start the Survey

Universal Study Design for Instrument Changes in Pharmaceutical Release AnalyticsPresentation by Dr. Anne Ries

Capillary Electrophoresis (CE) versus quantitative Polymerase Chain Reaction (qPCR) for direct quantification of intact adenovirus particlesPresentation by Dr. Francisca Galindo Garre

Expert Forum Panel Discussion

Presenters / Panellists

Anne Ries, PhD Scientist in Analytical Sciences and Technologies Boehringer Ingelheim (Germany) Anne Ries joined Boehringer Ingelheim in 2022. She works on various lifecycle topics in pharmaceutical release analytics, focusing on innovation during the post-approval phase of a biopharmaceutical product. Anne aims for efficient and digital solutions, as well as public accessibility and exchange across companies. Anne holds a biochemistry degree from the University of Tübingen, Germany, and completed her PhD in structural biology at ETH Zürich, Switzerland.

Francisca Galindo Garre, PhD Principal Scientist, Manufacturing Statistics Johnson & Johnson Innovative Medicine (Netherlands) Dr. Francisca holds a Master’s degree in Psychometrics, which she earned after completing her Bachelor’s in Psychology in Spain. Driven by her passion for research and data-driven methods, she moved to the Netherlands and pursued a PhD at Tilburg University, specialising in innovative methodologies for analysing categorical data. Following her doctoral studies, she further developed her expertise in biostatistics at the Academic Medical Center in Amsterdam. Currently, she works as a nonclinical statistician at Johnson & Johnson, where she supports projects focusing on analytical development and process characterisation.

Moderators

Prof. Dr. Cari Sänger-van de Griend Scientific Director BioQC Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.

Dr. Ewoud van Tricht Scientific Director BioQC Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.

Brought to you by:

Ask a Question

Join the conversation (or start a discussion) on the BioQC User Community.

Contact Us

If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry